MétaCan
Menu
Back to cohort
Record W4417004439 · doi:10.1182/blood-2025-630

Germline genetic testing uncovers a high frequency of inborn error of immunity diagnoses in children with single and multi-lineage immune cytopenias in a large US cohort

2025· article· en· W4417004439 on OpenAlexaff
Emily Harris, Thomas Pincez, Kirsty Hillier, Yi-Lee Ting, Jennifer MacWhirter - DiRaimo, Hannah L. Helber, Candelaria O’Farrell, Estelle Lecluze, Taylor Kim, Rachael F. Grace, Michael E. Scheurer, Rebecca Hale, Kristin A. Shimano, Diane J. Nugent, Ellis J. Neufeld, Craig D. Platt, Michele P. Lambert, Amanda B. Grimes, Shipra Kaicker

Bibliographic record

VenueBlood · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBlood disorders and treatments
Canadian institutionsUniversité de Montréal
Fundersnot available
KeywordsAutoimmune hemolytic anemiaGenetic testingNewborn screeningPrimary immunodeficiencyImmune systemNeutropeniaAutoimmunityCommon variable immunodeficiency

Abstract

fetched live from OpenAlex

Abstract Background Immune cytopenias including Immune Thrombocytopenia (ITP), Autoimmune Hemolytic Anemia (AIHA), or multilineage immune cytopenias/Evans syndrome (ES) can have variable clinical courses ranging from self-resolving to chronic or relapsing. They may occur in isolation or as the initial presentation of an underlying inborn error of immunity (IEI). Recent studies have found a high frequency of disease-causing variants in immune-related genes in children with ES. However, little is known about variants associated with single-lineage cytopenias. Aim To identify the prevalence of pathogenic (P) and likely pathogenic (LP) variants identified via clinical genetic testing in children with immune cytopenias. Methods This ITP Consortium of North America (ICON)-led retrospective study included children evaluated for immune cytopenias at centers across the United States who underwent clinical genetic testing through a commercial clinical laboratory (Invitae, now part of Labcorp). Included patients were age 0-21 years at time of genetic testing and had a diagnosis of ITP, AIHA, or ES as determined by clinician-provided ICD-10 code and/or recorded indication for genetic testing. Patients with isolated neutropenia were excluded from this study. Patients were included if their clinical genetic testing included any of the following targeted next generation sequencing (NGS) panels performed: Inborn Errors of Immunity and Cytopenias panel, Primary Immunodeficiency Panel, Autoimmune Lymphoproliferative Disorders (ALPS) Panel, Phagocytic Disorders Including Neutropenia Panel, Autoinflammatory and Autoimmunity Syndromes Panel, and/or Common Variable Immunodeficiency Panel. Variants identified as P or LP (P/LP), as determined by a semiquantitative, validated variant classification framework were evaluated in this study. Variants of uncertain significance were not included. Molecular IEI diagnosis was defined as presence of a single P/LP variant in monoallelic/autosomal dominant gene (or X-linked for individuals who are XY) or presence of two P/LP variants in a biallelic/autosomal recessive gene, depending on the gene and International Union of Immunological Societies (IUIS) classification. Results In total, there were 715 patients with immune cytopenias identified who had targeted NGS panels: 430 (60.1%) with ITP, 119 (16.6%) with AIHA, and 166 (23.2%) with ES. Median age at time of testing was 12 years (range 0-21) and 47.4% (n=339) were female. The frequency of patients with P/LP variants was 30.1% (215/715) in the total cohort, including 30.9% (133/430) in patients with ITP, 30.3% (36/119) in patients with AIHA, and 27.7% (46/166) in patients with ES. The most common variants identified were in genes related to diseases of immune dysregulation (37 patients), combined immunodeficiencies with associated syndromic features (33 patients), and immunodeficiencies affecting cellular and humoral immunity (29 patients). However, variants were spread across many IUIS categories at lower frequencies. Molecular IEI diagnoses were found in a subset of patients with P/LP variants. The frequency of molecular IEI diagnoses in the entire cohort was 7.7% (55/715), including 6.5% (28/430) in patients with ITP, 9.2% (11/119) in patients with AIHA, and 9.6% (16/166) in patients with ES. Median age of patients with IEI diagnoses was 13 years (range 2-20) and 30.9% (n=17) were female. The most common genetically identified conditions were related to dominantly inherited variants in TBX1 (n=8), CTLA4 (n=7), and STAT3 (n=4), associated with DiGeorge syndrome, CTLA4 haploinsufficiency, and STAT3 gain-of-function, respectively. Additionally, heterozygous TNFRSF13B variants were identified in 16 patients. Monoallelic variants in TNFRSF13B have been associated with increased risk of CVID with autoimmunity. Conclusions Genetically defined IEI were identified in approximately 7.7% of children with immune cytopenias who underwent genetic testing, and with similar frequency in children with single- and multi-lineage cytopenias. The high rate of genetic diagnoses in patients with single and multi-lineage immune cytopenias who were tested supports the clinical utility of genetic testing in these patients. Establishing these diagnoses informs selection of targeted therapies and potential need for stem cell transplant. Molecular diagnosis offers the opportunity for rational selection of targeted therapies rather than empiric broad immunosuppression.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.009
Threshold uncertainty score0.018

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.229
Teacher spread0.222 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBloodSame topicBlood disorders and treatmentsFrench-language works237,207